A method to codetect introduced genes and their products in gene therapy protocols
- 1 August 1996
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 14 (8) , 1012-1016
- https://doi.org/10.1038/nbt0896-1012
Abstract
To monitor the presence of introduced genes and the distribution of the encoded proteins in host tissues after gene transfer, we combined fluorescence in situ hybridization (FISH) and immunohistochemistry in two separate gene therapy paradigms. In brain tissue sections from animals injected with pHSVlac vector, we localized nuclei containing vector DNA both in cells expressing and not expressing beta-galactosidase (beta-gal). This suggests that the efficiency of gene transfer is affected not only by gene delivery, but also by cellular controls on gene expression. In a second paradigm, following myoblast transplantation, we detected donor nuclei in the muscle of a patient with Duchenne's muscular dystrophy. The donor nuclei were either surrounded by host nuclei or apparently fused in the patient's muscle fiber producing dystrophin. The combined FISH and immunohistochemistry assay offers greater sensitivity and more information than currently used polymerase chain reaction and protein detection methods.Keywords
This publication has 48 references indexed in Scilit:
- Muscle-Mediated Gene TherapyNew England Journal of Medicine, 1995
- Gene Therapy — A Novel Form of Drug DeliveryNew England Journal of Medicine, 1995
- Myoblast Transfer in the Treatment of Duchenne's Muscular DystrophyNew England Journal of Medicine, 1995
- A Controlled Study of Adenoviral-Vector–Mediated Gene Transfer in the Nasal Epithelium of Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson's DiseaseNew England Journal of Medicine, 1995
- Positional cloning moves from perditional to traditionalNature Genetics, 1995
- Heroic gene surgeryNature Genetics, 1994
- Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by 1-Methyl-4-Phenyl-L,2,3,6-Tetrahydropyridine (MPTP)New England Journal of Medicine, 1992
- Survival of Implanted Fetal Dopamine Cells and Neurologic Improvement 12 to 46 Months after Transplantation for Parkinson's DiseaseNew England Journal of Medicine, 1992
- Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantationNature, 1992